F. HOFFMANN-LA ROCHE LTD, MERCK KGAA, and THERMO FISHER SCIENTIFIC inc were Dominating the q-PCR Reagents Market in 2021

Global q-PCR Reagents Market is expected to grow with the CAGR of 6.6% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-q-pcr-reagents-market

Global q-PCR reagents market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global q-PCR reagents market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In January 2020, F. Hoffmann-La Roche Ltd announced the launch of the cobas Plasma Separation Card. This new solution is a stable and easy-to-use sample collection device for HIV plasma viral load testing. This has raised their sales and product portfolio
  • In March 2021, Merck KGaA announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia. This has increased the company’s product portfolio and sales

F. Hoffmann-La Roche Ltd is the dominating player in global q-PCR reagents market. The other key players existing in the market are Bio-Rad Laboratories, Inc., Agilent Technologies, Inc, Biotium, MiRXES Pte Ltd, GeneDireX, Inc, Norgen Biotek Corp, Takara Holdings Inc., Enzo Biochem Inc, Qiagen, PCR Biosystems, Tonbo Biosciences, Quantabio, Merck KgaA, Kaneka Eurogentec S.A, Promega Corporation, Solis BioDyne, Seegene Inc., Sino Biological Inc, Thermo Fisher Scientific Inc, TRANSGENE BIOTEK LIMITED, New England Biolabs,  Empirical Bioscience, Inc., YouSeq Ltd, and Bioneer Corporation among others.

q-PCR Reagents MarketF. HOFFMANN-LA ROCHE LTD

F. Hoffmann-La Roche Ltd company was founded in the year 1896 and is headquarter in Basel, Switzerland. The company is engaged in creating innovative medicines and diagnostics tests that help millions of people worldwide.

Company provide products via various product category such as sample collection, nucleic acid extraction, PCR, RNA library prep, qPCR, oncology assays and bioinformatics in which qPCR is market focused.

For instance,

  • In January 2021, F. Hoffmann-La Roche Ltd announced the launch of the cobas Plasma Separation Card. This new solution is a stable and easy-to-use sample collection device for HIV plasma viral load testing. This has raised their sales and product portfolio

The company has wide presence across Americas, Europe, Asia-Pacific. and Middle East and Africa. The company also has various subsidiary such as Roche Diagnostica Brasil Ltda. (Brazil), Roche Diabetes Care Brasil Ltda. (Brazil), Trophos SA (France), INSTITUT ROCHE SAS (France) and Roche Diagnostics K.K. (Japan) among more.

MERCK KGAA

Merck KgaA was founded in the year 1891 and is headquartered in Darmstadt, Germany. The company focuses on inventing life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. Company provide products via various product category such as analytics and sample preparation, biopharmaceutical manufacturing, industrial microbiology, IVD/OEM materials and reagents, life science research, reagents, chemicals and labware, small molecule pharmaceuticals and water purification in which life science research is market focused.

For instance,

  • In July 2020, Merck KGaA announced that they are planning to build a new, USD 20.44 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business. This will increase the company’s production and R&D activity

The company has presence across North America, Europe, Middle East and Africa, Asia-Pacific. The company also has various subsidiaries including BioControl Systems Limited (London), Merck Ltd (Feltham), EMD Digital Holdings LLC (U.S.), Merck Foundation gGmbH (Germany), Sigma Chemical Co. Ltd. (London) Among others

THERMO FISHER SCIENTIFIC INC

Thermo Fisher Scientific Inc. was founded in the year 1891 and is headquartered in Massachusetts, U.S. The company focuses on providing products for life sciences research, solving complex analytical challenges and improving patient diagnostics and therapies or increasing productivity in the laboratories.

Company provide products via various product category such industrial & applied science, life sciences, clinical & diagnostics in which life sciences is market focused.

For instance,

  • In December 2021, Thermo Fisher Scientific Inc. announced that they have completed the acquisition of PPD, Inc a leading global provider of clinical research services to the biopharma and biotech industry. This acquisition has helped the company to increase the product portfolio and sales

The company has presence across Asia-Pacific, Middle East & Africa, Latin America, and Europe. The company has various subsidiaries including Thermo Fisher Scientific Operating Company LLC (Delaware), Thermo Fisher Scientific Senior Financing LLC (Delaware), Thermo Fisher Scientific (DE) Holding S.a.r.l. (Luxembourg), Laboratory Management Systems, Inc. (Delaware), Thermo Fisher Scientific Peru S.R.L (Peru) among others.